Velocity Clinical Research

Velocity Clinical Research specializes in delivering clinical trial services and data to biopharmaceutical and contract research organizations. The company focuses on facilitating the successful execution of clinical studies by offering comprehensive support in areas such as feasibility assessment, contracting, patient recruitment, study management, and billing. By ensuring a centralized point of contact for these services, Velocity aids its clients in upholding high standards of care while expediting the development and deployment of innovative medical treatments across various therapeutic areas. The company is dedicated to connecting new medications to the patients who need them promptly and effectively.

Nicholas Spittal

COO

10 past transactions

Meridian Clinical Research

Acquisition in 2022
Meridian Clinical Research is a multi-specialty network focused on facilitating clinical trials for pharmaceutical and biotechnology companies. The organization conducts studies across phases 1 to 4, covering a wide range of therapeutic areas. It is particularly noted for its expertise in high-volume vaccine trials, which plays a crucial role in the development of new drugs, medical devices, and diagnostic tools. By providing comprehensive clinical research services, Meridian Clinical Research supports the advancement of medical innovations aimed at enhancing human health and well-being.

Egin Research

Acquisition in 2022
Egin Research operates a network of dedicated clinical research centers that cater to pharmaceutical companies worldwide. The organization specializes in conducting clinical trials across various therapeutic areas, including autoimmune diseases, respiratory issues, internal medicine, diabetes, dermatology, and women's health. By focusing on these diverse fields, Egin Research facilitates the safe and accurate execution of clinical trials, ensuring that pharmaceutical companies can rely on their expertise for effective research outcomes.

MedPharmics

Acquisition in 2022
MedPharmics is a clinical research center that specializes in providing comprehensive clinical research services to assess the efficacy and safety of medications. The organization focuses on various areas, including primary care, women's health, vaccines, and pediatric trials. By ensuring quality management of clinical trials, MedPharmics supports its clients in maintaining high standards of care throughout the research process.

Clinical Research Hamburg

Acquisition in 2022
Clinical Research Hamburg is an outpatient test center for clinical research phases II, III and IV.

Trier Health

Acquisition in 2022
Trier Health operates a digital clinical trials platform called DeepCentric, designed to enhance patient experience and improve the efficiency of clinical trial execution. The platform facilitates both hybrid and fully decentralized trials, placing the patient at the core of the process. By leveraging advanced analytics and artificial intelligence, DeepCentric enriches collaboration between patients and clinicians while enhancing patient engagement. Trier Health emphasizes data security through biometric authentication and a blockchain framework, ensuring controlled access and protecting sensitive information. The company's innovative approach aims to transform the delivery of healthcare, ultimately improving care quality and operational efficiencies in clinical trials.

Riverside Clinical Research

Acquisition in 2021
Riverside Clinical Research is a company that specializes in clinical research trials.

Downtown Women's Health Care

Acquisition in 2021
Downtown Women's Health Care is a private clinic focused on providing comprehensive women's health care services and conducting gynecological clinical research. The clinic specializes in various women's health studies, with particular emphasis on conditions such as endometriosis, the effects of birth control, and research related to hot flashes. Through its dedicated approach, Downtown Women's Health Care aims to advance knowledge and treatment options in the field of women's health.

eStudySite

Acquisition in 2020
eStudySite, Inc. is a clinical research organization that specializes in conducting Phase II and Phase III clinical trials across various therapeutic areas, including endocrinology, hepatology, dermatology, gastroenterology, and infectious diseases. The company focuses on conditions such as NASH, NAFLD, Type 2 diabetes, and various gastrointestinal disorders, as well as women's health and orphan diseases. Founded in 1999 and headquartered in La Mesa, California, with an additional office in Las Vegas, Nevada, eStudySite also employs proprietary software to manage a diverse database of participants. As a subsidiary of VCR Holdings, LLC, eStudySite aims to enhance the clinical research process to facilitate the development and accessibility of new medications globally.

Rapid Medical Research

Acquisition in 2019
Rapid Medical Research is an independent research center specializing in Phase I-IV clinical trials. The organization operates as a clinical trials management entity, focusing on data collection services that enhance the medical community's understanding of disease mechanisms. Through its dedicated efforts in clinical research, Rapid Medical Research contributes to advancing medical knowledge and improving patient outcomes.

Advanced Clinical Research

Acquisition in 2019
Advanced Clinical Research is a specialized organization focused on multi-therapeutic clinical research. As a clinical trials management entity, it is dedicated to delivering high-quality data collection services to the medical community. By facilitating clinical research, Advanced Clinical Research enhances the understanding of disease mechanisms, thereby contributing to advancements in medical knowledge and treatment options. Its commitment to superior service positions the organization as a key player in the field of clinical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.